Últimas publicaciones
- Rössler J, Eulalia Baselga Torres, Davila V, Celis-Passini V, Diociaiuti A, El Hachem M, Mestre S, Haeberli D, Prokop A, Hanke C, Loichinger W, Quéré I, Baumgartner I, Niemeyer CM and Kapp FG Severe adverse events during sirolimus "off-label" therapy for vascular anomalies. PEDIATRIC BLOOD & CANCER . 68(8): e28936.
- Carrere X, Pinto N, Gene-Olaciregui N, Galluzzo L, Rossetti E, Celis-Passini V, Salvador-Marcos N, Chantada G, Braier J, Lavarino C and Felizzia G High prevalence of BRAF(V600E) in patients with cholestasis, sclerosing cholangitis or liver fibrosis secondary to Langerhans cell histiocytosis. PEDIATRIC BLOOD & CANCER . 68(7): e29115.
- Castillo-Ecija H, Pascual-Pastó G, Pérez-Jaume S, Resa-Pares C, Vilà-Ubach M, Monterrubio C, Jimenez-Cabaco A, Baulenas-Farres M, Muñoz-Aznar O, Salvador-Marcos N, Cuadrado-Vilanova M, Gene-Olaciregui N, Balaguer-Lluna L, Burgueño V, Vicario FJ, Manzanares-Quintela A, Castañeda-Heredia A, Santa-María López V, Cruz-Martínez O, Celis-Passini V, Morales-La Madrid A, Garraus-Oneca M, Gorostegui M, Vancells M, Carrasco-Torrents R, Krauel L, Torner-Rubies F, Suñol M, Lavarino C, Mora J and Carcaboso AM Prognostic value of patient-derived xenograft engraftment in pediatric sarcomas. JOURNAL OF PATHOLOGY CLINICAL RESEARCH . 7(4): 338-349.